Lipophilic adamantyl- or deferasirox-based conjugates of desferrioxamine B have enhanced neuroprotective capacity: implications for Parkinson disease.
about
Iron chelation and multiple sclerosisActivation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer's disease through inhibition of inflammationPyrrolidine dithiocarbamate activates the Nrf2 pathway in astrocytes.Insights on the interaction of alpha-synuclein and metals in the pathophysiology of Parkinson's disease.Targeting mitochondrial metal dyshomeostasis for the treatment of neurodegeneration.Does any drug to treat cancer target mTOR and iron hemostasis in neurodegenerative disorders?Analogues of desferrioxamine B designed to attenuate iron-mediated neurodegeneration: synthesis, characterisation and activity in the MPTP-mouse model of Parkinson's disease.Profiling the iron, copper and zinc content in primary neuron and astrocyte cultures by rapid online quantitative size exclusion chromatography-inductively coupled plasma-mass spectrometry.In vitro antiproliferative study of novel adamantyl pyridin-4-ones.
P2860
Q27001743-21F85278-8F6C-4BCA-BFF7-07B87198E3C5Q35025065-2E5BC6AC-3D9B-451E-B45D-F139E3AB6AB2Q36622182-00086495-F424-4F2F-B435-E9D4DCC165E6Q38343049-A66180B4-CBD6-4B03-B981-B57E3A14DF67Q38570991-D6C7FF17-1CA3-4222-9DEC-0D0D1BFB4544Q39010650-031167A0-1ED3-4125-B901-9E1506A59C2AQ46372704-B1305FB9-4399-4366-A144-B9DEC1E15631Q46981792-AC3D2C60-9030-43DE-AEEF-E32C6CE10B18Q48147543-C7238390-9F41-474B-93A6-9E44BA7A5248
P2860
Lipophilic adamantyl- or deferasirox-based conjugates of desferrioxamine B have enhanced neuroprotective capacity: implications for Parkinson disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Lipophilic adamantyl- or defer ...... cations for Parkinson disease.
@en
Lipophilic adamantyl- or defer ...... cations for Parkinson disease.
@nl
type
label
Lipophilic adamantyl- or defer ...... cations for Parkinson disease.
@en
Lipophilic adamantyl- or defer ...... cations for Parkinson disease.
@nl
prefLabel
Lipophilic adamantyl- or defer ...... cations for Parkinson disease.
@en
Lipophilic adamantyl- or defer ...... cations for Parkinson disease.
@nl
P2093
P50
P1476
Lipophilic adamantyl- or defer ...... cations for Parkinson disease.
@en
P2093
Daniel Obando
George Ganio
Su San Mok
P304
P356
10.1016/J.FREERADBIOMED.2013.01.027
P577
2013-02-04T00:00:00Z